Bio Green Med Solution, Inc. 8-K

What Happened
Bio Green Med Solution, Inc. (filed 8-K on March 13, 2026) announced that Nasdaq has determined its 6% Convertible Exchangeable Preferred Stock (symbol BGMSP) no longer meets the minimum Market Value of Publicly Held Shares (MVPHS) requirement and will be delisted. The company received Nasdaq’s delisting notification on March 12, 2026 and does not intend to seek an appeal, so trading of the Preferred Stock is expected to be suspended and then removed from Nasdaq on or after April 2, 2026.

Key Details

• The Preferred Stock failed to maintain the MVPHS requirement of $1.0 million; Nasdaq first notified the company of noncompliance on September 11, 2025.
• Nasdaq gave the company 180 days (through March 10, 2026) to regain compliance; Nasdaq’s March 12, 2026 letter confirmed compliance was not regained.
• Appeal deadline was March 19, 2026; the company will not appeal. Suspension of trading was scheduled to begin March 23, 2026, and formal removal will follow via Form 25-NSE.
• The delisting applies only to the 6% Convertible Exchangeable Preferred Stock (BGMSP); the company’s Common Stock (BGMS) remains listed on Nasdaq. The company believes the Preferred Stock may be quoted and traded on OTC Markets after April 2, 2026.

Why It Matters
For holders of the Preferred Stock, delisting from Nasdaq typically means reduced liquidity, potentially wider bid/ask spreads, and trading on less-regulated venues such as the OTC Markets. The filing confirms the company will not pursue an appeal, so the delisting is expected to proceed. The company’s common shares (BGMS) are not affected by this action and will remain listed on Nasdaq. Investors should review the company’s filings for more details and consider the change in trading venue and liquidity for the Preferred Stock.